160 related articles for article (PubMed ID: 32784094)
1. Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography-mass spectrometry.
Fan Y; Noreldeen HAA; You L; Liu X; Pan X; Hou Z; Li Q; Li X; Xu G
J Pharm Biomed Anal; 2020 Oct; 190():113520. PubMed ID: 32784094
[TBL] [Abstract][Full Text] [Related]
2. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
3. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid profiling analysis and potential marker discovery for ovarian cancer based on liquid chromatography-Mass spectrometry.
Wang Y; Wang Y; Chen C; Ren F; Cao R; Wang Y; Han P; Zhang X; Xu C; Liu X; Xu G
J Pharm Biomed Anal; 2021 May; 199():114048. PubMed ID: 33836461
[TBL] [Abstract][Full Text] [Related]
5. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
[TBL] [Abstract][Full Text] [Related]
6. Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography-Mass Spectrometry.
Wang L; Hu C; Liu S; Chang M; Gao P; Wang L; Pan Z; Xu G
J Proteome Res; 2016 Jun; 15(6):1986-94. PubMed ID: 27151145
[TBL] [Abstract][Full Text] [Related]
7. Screening and identification of potential novel lipid biomarkers for non-small cell lung cancer using ultra-high performance liquid chromatography tandem mass spectrometry.
Han YS; Shi LY; Chen JX; Chen J; Li ZB; Lu QQ; Zhang SQ; Liu J; Yi WJ; Jiang TT; Li JC; Huang J
Anat Rec (Hoboken); 2022 May; 305(5):1087-1099. PubMed ID: 34347376
[TBL] [Abstract][Full Text] [Related]
8. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
[No Abstract] [Full Text] [Related]
9. Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer.
Ho YS; Yip LY; Basri N; Chong VS; Teo CC; Tan E; Lim KL; Tan GS; Yang X; Yeo SY; Koh MS; Devanand A; Takano A; Tan EH; Tan DS; Lim TK
Sci Rep; 2016 Oct; 6():35110. PubMed ID: 27739449
[TBL] [Abstract][Full Text] [Related]
10. One-step lipid extraction for plasma lipidomics analysis by liquid chromatography mass spectrometry.
Satomi Y; Hirayama M; Kobayashi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():93-100. PubMed ID: 28850891
[TBL] [Abstract][Full Text] [Related]
11. Untargeted Lipidomics Reveals Specific Lipid Abnormalities in Nonfunctioning Human Pituitary Adenomas.
Hu C; Zhou Y; Feng J; Zhou S; Li C; Zhao S; Shen Y; Hong L; Xuan Q; Liu X; Li Q; Wang X; Zhang Y; Xu G
J Proteome Res; 2020 Jan; 19(1):455-463. PubMed ID: 31601105
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
Marien E; Meister M; Muley T; Fieuws S; Bordel S; Derua R; Spraggins J; Van de Plas R; Dehairs J; Wouters J; Bagadi M; Dienemann H; Thomas M; Schnabel PA; Caprioli RM; Waelkens E; Swinnen JV
Int J Cancer; 2015 Oct; 137(7):1539-48. PubMed ID: 25784292
[TBL] [Abstract][Full Text] [Related]
13. Lipidomics by HILIC-Ion Mobility-Mass Spectrometry.
Li A; Hines KM; Xu L
Methods Mol Biol; 2020; 2084():119-132. PubMed ID: 31729657
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in analytical strategies for mass spectrometry-based lipidomics.
Xu T; Hu C; Xuan Q; Xu G
Anal Chim Acta; 2020 Nov; 1137():156-169. PubMed ID: 33153599
[TBL] [Abstract][Full Text] [Related]
15. Mass Spectrometry Applied to Human Cerebrospinal Fluid Lipidome.
Millán L; Fernández-Irigoyen J; Santamaría E; Mayo R
Methods Mol Biol; 2019; 2044():353-361. PubMed ID: 31432425
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis.
Wang G; Qiu M; Xing X; Zhou J; Yao H; Li M; Yin R; Hou Y; Li Y; Pan S; Huang Y; Yang F; Bai F; Nie H; Di S; Guo L; Meng Z; Wang J; Yin Y
Sci Transl Med; 2022 Feb; 14(630):eabk2756. PubMed ID: 35108060
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
18. Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain.
Tu J; Yin Y; Xu M; Wang R; Zhu ZJ
Metabolomics; 2017 Nov; 14(1):5. PubMed ID: 30830317
[TBL] [Abstract][Full Text] [Related]
19. The state of the art in plant lipidomics.
Kehelpannala C; Rupasinghe T; Hennessy T; Bradley D; Ebert B; Roessner U
Mol Omics; 2021 Dec; 17(6):894-910. PubMed ID: 34699583
[TBL] [Abstract][Full Text] [Related]
20. Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.
Yang K; Han X
Trends Biochem Sci; 2016 Nov; 41(11):954-969. PubMed ID: 27663237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
